During Q4 2018 the big money sentiment decreased to 0.81. That’s change of 0.16, from 2018Q3’s 0.97. 79 investors sold all, 238 reduced holdings as Laboratory Corporation of America Holdings ratio worsened. 193 rose positions while 64 funds took positions. Funds hold 88.30 million shares thus 0.88% less from 2018Q3’s 89.08 million shares.
Rhenman & Asset Management Ab stated it has 0.16% in Laboratory Corporation of America Holdings (NYSE:LH). Hilltop Hldgs holds 1,932 shs. Manufacturers Life Ins Commerce The has 100,021 shs. Aqr Mgmt Ltd Liability Corp reported 0.13% of its capital in Laboratory Corporation of America Holdings (NYSE:LH). Weitz Mgmt Incorporated reported 689,325 shs or 3.99% of all its holdings. Pub Employees Retirement System Of Ohio has 0.07% invested in Laboratory Corporation of America Holdings (NYSE:LH). Supplemental Annuity Collective Tru Of Nj holds 0.32% of its capital in Laboratory Corporation of America Holdings (NYSE:LH) for 5,000 shs. Sandy Spring Financial Bank owns 0.36% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 29,494 shs. Barclays Public Limited Liability Corp invested in 158,544 shs. Evermay Wealth Ltd Llc invested 0.17% in Laboratory Corporation of America Holdings (NYSE:LH). Maverick Cap Limited owns 88,200 shs for 0.16% of their capital. The New Jersey-based Advisors Mngmt Lc has invested 0.2% in Laboratory Corporation of America Holdings (NYSE:LH). Netherlands-based Robeco Institutional Asset Bv has invested 0.01% in Laboratory Corporation of America Holdings (NYSE:LH). Great West Life Assurance Can reported 74,846 shs stake. South Dakota Invest Council invested 0.03% of its capital in Laboratory Corporation of America Holdings (NYSE:LH).
Laboratory Corporation of America Holdings registered $1.35 million net activity with 0 buys and 4 insider sales since November 5, 2018. ANDERSON KERRII B had sold 3,700 shs worth $604,162 on Monday, November 5. BELINGARD JEAN-LUC sold $540,407 worth of stock or 3,700 shs.
Earnings report for Laboratory Corporation of America Holdings (NYSE:LH) is anticipated on April, 24., according to Faxor. earnings per share of $2.55 is 8.27 % down from 2018’s $2.78 EPS. LH’s profit could be $251.43 million if the current earnings per share of $2.55 is accurate. 1.19 % EPS growth is what Wall Street’s sees after $2.52 reported EPS last quarter. LH touched $150.91 during the last trading session after $0.23 change.Laboratory Corporation of America Holdings is downtrending after having declined 13.69% since March 27, 2018. LH has 859,742 volume or 3.78% up from normal. The stock underperformed the S&P 500 by 18.06%.
Laboratory Corporation of America Holdings (NYSE:LH) Ratings Coverage
In total 11 analysts cover Laboratory Corp (NYSE:LH). “Buy” rating has 7, “Sell” are 1, while 3 are “Hold”. (NYSE:LH) has 64% bullish analysts. 17 are the (NYSE:LH)’s ratings reports on Mar 27, 2019 according to StockzIntelligence Inc. On Monday, December 3 the stock has “Overweight” rating by Barclays Capital. On Thursday, January 3 the firm earned “Underperform” rating by Bank of America. The company rating was maintained by Barclays Capital on Monday, March 18. On Wednesday, February 27 the stock has “Outperform” rating by Credit Suisse. On Monday, December 3 the company was maintained by Morgan Stanley. On Monday, December 3 the stock of Laboratory Corporation of America Holdings (NYSE:LH) has “Hold” rating given by Canaccord Genuity. On Friday, February 22 the stock has “Buy” rating by Morgan Stanley. On Thursday, October 25 Citigroup maintained Laboratory Corporation of America Holdings (NYSE:LH) with “Neutral” rating. On Thursday, October 25 the firm has “Hold” rating given by Canaccord Genuity. On Monday, December 3 the firm earned “Neutral” rating by Citigroup.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide.The firm is worth $14.88 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development.17.53 is the P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.
More recent Laboratory Corporation of America Holdings (NYSE:LH) news were released by Globenewswire.com, Globenewswire.com and Businesswire.com. The first one has “Recent Analysis Shows Transocean, Chipotle Mexican Grill, Marathon Oil, Laboratory Corporation of America, Bio-Rad Laboratories, and Graco Market Influences — Renewed Outlook, Key Drivers of Growth – GlobeNewswire” as a title and was released on March 27, 2019. The next is “MagnaCare Announces Collaboration with BeaconLBS to Help Physicians Select Laboratory Tests that Can Improve Patient Care and Reduce Costs – GlobeNewswire” on March 13, 2019. And last was released on March 11, 2019, called “LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest – Business Wire”.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.